BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jang H, Kim TK, Burns PN, Wilson SR. CEUS: An essential component in a multimodality approach to small nodules in patients at high-risk for hepatocellular carcinoma. European Journal of Radiology 2015;84:1623-35. [DOI: 10.1016/j.ejrad.2015.05.020] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 5.3] [Reference Citation Analysis]
Number Citing Articles
1 Danno K, Nakamura T, Okoso N, Nakamura N, Iguchi K, Iwadate Y, Kenmotsu T, Ikegawa M, Uemoto S, Yoshikawa K. Cracking pattern of tissue slices induced by external extension provides useful diagnostic information. Sci Rep 2018;8:12167. [PMID: 30111854 DOI: 10.1038/s41598-018-30662-9] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
2 Kang HJ, Lee JM, Yoon JH, Han JK. Role of Contrast-Enhanced Ultrasound as a Second-Line Diagnostic Modality in Noninvasive Diagnostic Algorithms for Hepatocellular Carcinoma. Korean J Radiol 2021;22:354-65. [PMID: 33236540 DOI: 10.3348/kjr.2020.0973] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
3 Omata M, Cheng AL, Kokudo N, Kudo M, Lee JM, Jia J, Tateishi R, Han KH, Chawla YK, Shiina S, Jafri W, Payawal DA, Ohki T, Ogasawara S, Chen PJ, Lesmana CRA, Lesmana LA, Gani RA, Obi S, Dokmeci AK, Sarin SK. Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update. Hepatol Int. 2017;11:317-370. [PMID: 28620797 DOI: 10.1007/s12072-017-9799-9] [Cited by in Crossref: 661] [Cited by in F6Publishing: 667] [Article Influence: 132.2] [Reference Citation Analysis]
4 Fu J, Yang W, Wang S, Bai J, Wu H, Wang H, Yan K, Chen M. Clinical value of contrast-enhanced ultrasound in improving diagnostic accuracy rate of transthoracic biopsy of anterior-medial mediastinal lesions. Chin J Cancer Res 2016;28:617-25. [PMID: 28174490 DOI: 10.21147/j.issn.1000-9604.2016.06.08] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
5 Polikoff A, Wessner CE, Balasubramanya R, Dulka S, Liu JB, Machado P, Savsani E, Lyshchik A, Shaw CM, Eisenbrey JR. Imaging appearance of residual HCC following incomplete trans-arterial chemoembolization on contrast-enhanced imaging. Abdom Radiol (NY) 2021. [PMID: 34643782 DOI: 10.1007/s00261-021-03298-z] [Reference Citation Analysis]
6 Kim JH, Yoon JH, Joo I, Lee JM. Evaluation of Primary Liver Cancers Using Hepatocyte-Specific Contrast-Enhanced MRI: Pitfalls and Potential Tips. J Magn Reson Imaging 2021;53:655-75. [PMID: 32700807 DOI: 10.1002/jmri.27213] [Reference Citation Analysis]
7 Li F, Li Q, Liu Y, Han J, Zheng W, Huang Y, Zheng X, Cao L, Zhou J. Distinguishing intrahepatic cholangiocarcinoma from hepatocellular carcinoma in patients with and without risks: the evaluation of the LR-M criteria of contrast-enhanced ultrasound liver imaging reporting and data system version 2017. Eur Radiol 2020;30:461-70. [DOI: 10.1007/s00330-019-06317-2] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
8 Liu X, Jang H, Khalili K, Kim TK, Atri M. Successful Integration of Contrast-enhanced US into Routine Abdominal Imaging. RadioGraphics 2018;38:1454-77. [DOI: 10.1148/rg.2018170152] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
9 Shao YY, Wang SY, Lin SM; Diagnosis Group,., Systemic Therapy Group. Management consensus guideline for hepatocellular carcinoma: 2020 update on surveillance, diagnosis, and systemic treatment by the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan. J Formos Med Assoc 2021;120:1051-60. [PMID: 33199101 DOI: 10.1016/j.jfma.2020.10.031] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
10 Huang Z, Zhou P, Li S, Li K. MR versus CEUS LI-RADS for Distinguishing Hepatocellular Carcinoma from other Hepatic Malignancies in High-Risk Patients. Ultrasound Med Biol 2021;47:1244-52. [PMID: 33610338 DOI: 10.1016/j.ultrasmedbio.2021.01.020] [Reference Citation Analysis]
11 Bhogadi Y, Brown E, Lee SY. Contrast-enhanced ultrasound in the diagnosis of infiltrative hepatocellular carcinoma: A report of three cases. Radiol Case Rep 2021;16:448-56. [PMID: 33363680 DOI: 10.1016/j.radcr.2020.11.043] [Reference Citation Analysis]
12 Miller DL, Lu X, Fabiilli M, Dou C. Hepatocyte Injury Induced by Contrast-Enhanced Diagnostic Ultrasound. J Ultrasound Med 2019;38:1855-64. [PMID: 30548874 DOI: 10.1002/jum.14883] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
13 Park S, You MW, Kang HJ, Moon SK, Park SJ. Contrast-Enhanced Ultrasound for Focal Hepatic Lesions: When to Use and How to Differentiate Lesions? Ultrasound Q 2020;36:224-34. [PMID: 32890325 DOI: 10.1097/RUQ.0000000000000475] [Reference Citation Analysis]
14 Cassinotto C, Aubé C, Dohan A. Diagnosis of hepatocellular carcinoma: An update on international guidelines. Diagn Interv Imaging 2017;98:379-91. [PMID: 28395852 DOI: 10.1016/j.diii.2017.01.014] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 4.6] [Reference Citation Analysis]
15 Spann S, Fetzer DT. Contrast-Enhanced Ultrasound in Chronic Liver Diseases. Magn Reson Imaging Clin N Am 2021;29:291-304. [PMID: 34243918 DOI: 10.1016/j.mric.2021.05.006] [Reference Citation Analysis]
16 Bartolotta TV, Terranova MC, Gagliardo C, Taibbi A. CEUS LI-RADS: a pictorial review. Insights Imaging. 2020;11:9. [PMID: 32020352 DOI: 10.1186/s13244-019-0819-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
17 Windrim R, Kingdom J, Jang H, Burns PN. Contrast enhanced ultrasound (CEUS) in the prenatal evaluation of suspected invasive placenta percreta. Journal of Obstetrics and Gynaecology Canada 2016;38:975-8. [DOI: 10.1016/j.jogc.2016.06.012] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
18 Kim TH, Kim SY, Tang A, Lee JM. Comparison of international guidelines for noninvasive diagnosis of hepatocellular carcinoma: 2018 update. Clin Mol Hepatol 2019;25:245-63. [PMID: 30759967 DOI: 10.3350/cmh.2018.0090] [Cited by in Crossref: 82] [Cited by in F6Publishing: 77] [Article Influence: 27.3] [Reference Citation Analysis]
19 Miller DL, Lu X, Fabiilli M, Dou C. Influence of Microbubble Size and Pulse Amplitude on Hepatocyte Injury Induced by Contrast-Enhanced Diagnostic Ultrasound. Ultrasound Med Biol 2019;45:170-6. [PMID: 30366606 DOI: 10.1016/j.ultrasmedbio.2018.09.011] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
20 Aubé C, Bazeries P, Lebigot J, Cartier V, Boursier J. Liver fibrosis, cirrhosis, and cirrhosis-related nodules: Imaging diagnosis and surveillance. Diagnostic and Interventional Imaging 2017;98:455-68. [DOI: 10.1016/j.diii.2017.03.003] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
21 Liu D, Gu X, Liu F, Shi F, Yang M, Wu Q. Application of contrast-enhanced ultrasound for scar pregnancy cases misdiagnosed as other diseases. Clin Chim Acta 2019;496:134-9. [PMID: 31173731 DOI: 10.1016/j.cca.2019.06.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
22 Kang H, Lee JM, Yoon JH, Lee K, Kim H, Han JK. Contrast-enhanced US with Sulfur Hexafluoride and Perfluorobutane for the Diagnosis of Hepatocellular Carcinoma in Individuals with High Risk. Radiology 2020;297:108-16. [DOI: 10.1148/radiol.2020200115] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
23 Lyshchik A, Kono Y, Dietrich CF, Jang HJ, Kim TK, Piscaglia F, Vezeridis A, Willmann JK, Wilson SR. Contrast-enhanced ultrasound of the liver: technical and lexicon recommendations from the ACR CEUS LI-RADS working group. Abdom Radiol (NY). 2018;43:861-879. [PMID: 29151131 DOI: 10.1007/s00261-017-1392-0] [Cited by in Crossref: 48] [Cited by in F6Publishing: 39] [Article Influence: 16.0] [Reference Citation Analysis]
24 Zhou HL, Tang CL. Clinical value of contrast-enhanced ultrasound in radiofrequency ablation for primary hepatocellular carcinoma undetectable by conventional ultrasound. Shijie Huaren Xiaohua Zazhi 2019; 27(8): 503-508 [DOI: 10.11569/wcjd.v27.i8.503] [Reference Citation Analysis]
25 Hsiao CY, Chen PD, Huang KW. A Prospective Assessment of the Diagnostic Value of Contrast-Enhanced Ultrasound, Dynamic Computed Tomography and Magnetic Resonance Imaging for Patients with Small Liver Tumors. J Clin Med 2019;8:E1353. [PMID: 31480576 DOI: 10.3390/jcm8091353] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
26 Kang H, Kim JH, Joo I, Han JK. Additional value of contrast-enhanced ultrasound (CEUS) on arterial phase non-hyperenhancement observations (≥ 2 cm) of CT/MRI for high-risk patients: focusing on the CT/MRI LI-RADS categories LR-3 and LR-4. Abdom Radiol 2020;45:55-63. [DOI: 10.1007/s00261-019-02132-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
27 Aubé C, Oberti F, Lonjon J, Pageaux G, Seror O, N'Kontchou G, Rode A, Radenne S, Cassinotto C, Vergniol J, Bricault I, Leroy V, Ronot M, Castera L, Michalak S, Esvan M, Vilgrain V; CHIC Group. EASL and AASLD recommendations for the diagnosis of HCC to the test of daily practice. Liver Int 2017;37:1515-25. [PMID: 28346737 DOI: 10.1111/liv.13429] [Cited by in Crossref: 48] [Cited by in F6Publishing: 47] [Article Influence: 9.6] [Reference Citation Analysis]
28 Xie DY, Ren ZG, Zhou J, Fan J, Gao Q. Critical appraisal of Chinese 2017 guideline on the management of hepatocellular carcinoma. Hepatobiliary Surg Nutr. 2017;6:387-396. [PMID: 29312973 DOI: 10.21037/hbsn.2017.11.01] [Cited by in Crossref: 31] [Cited by in F6Publishing: 36] [Article Influence: 6.2] [Reference Citation Analysis]
29 Liu LF, Ding ZL, Zhong JH, Li HX, Liu JJ, Li H, Li LQ. Contrast-Enhanced Ultrasound to Monitor Early Recurrence of Primary Hepatocellular Carcinoma after Curative Treatment. Biomed Res Int 2018;2018:8910562. [PMID: 30533441 DOI: 10.1155/2018/8910562] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
30 Wilson SR, Burns PN, Kono Y. Contrast-Enhanced Ultrasound of Focal Liver Masses: A Success Story. Ultrasound Med Biol 2020;46:1059-70. [PMID: 32059917 DOI: 10.1016/j.ultrasmedbio.2019.12.021] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
31 Ling W, Wang M, Ma X, Qiu T, Li J, Lu Q, Luo Y. The preliminary application of liver imaging reporting and data system (LI-RADS) with contrast-enhanced ultrasound (CEUS) on small hepatic nodules (≤ 2cm). J Cancer 2018;9:2946-52. [PMID: 30123363 DOI: 10.7150/jca.25539] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 4.5] [Reference Citation Analysis]
32 Zhu WN. Diagnostic value of contrast-enhanced ultrasound versus magnetic resonance imaging in extrahepatic cholangiocarcinoma. Shijie Huaren Xiaohua Zazhi 2018; 26(13): 796-802 [DOI: 10.11569/wcjd.v26.i13.796] [Cited by in CrossRef: 1] [Article Influence: 0.3] [Reference Citation Analysis]
33 Kim TH, Yang HK, Jang HJ, Yoo SJ, Khalili K, Kim TK. Abdominal imaging findings in adult patients with Fontan circulation. Insights Imaging 2018;9:357-67. [PMID: 29623675 DOI: 10.1007/s13244-018-0609-2] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 4.5] [Reference Citation Analysis]
34 Maruyama H, Sekimoto T, Yokosuka O. Role of contrast-enhanced ultrasonography with Sonazoid for hepatocellular carcinoma: evidence from a 10-year experience. J Gastroenterol 2016;51:421-33. [PMID: 26694825 DOI: 10.1007/s00535-015-1151-3] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.6] [Reference Citation Analysis]
35 Kobayashi K, Maruyama H, Kiyono S, Yokosuka O, Ohtsuka M, Miyazaki M, Matsushima J, Kishimoto T, Nakatani Y. Histology-Based Assessment of Sonazoid-Enhanced Ultrasonography for the Diagnosis of Liver Metastasis. Ultrasound in Medicine & Biology 2017;43:2151-8. [DOI: 10.1016/j.ultrasmedbio.2017.06.014] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
36 Bartolotta TV, Taibbi A, Midiri M, Lagalla R. Contrast-enhanced ultrasound of hepatocellular carcinoma: where do we stand? Ultrasonography 2019;38:200-14. [PMID: 31006227 DOI: 10.14366/usg.18060] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 6.3] [Reference Citation Analysis]
37 Jianmin DM, Yan ZM, Yandong WM, Hongyu ZM, Xiang JM. Clinical Value of Contrast-enhanced Ultrasound in Differential Diagnosis of Early Hepatocellular Carcinoma and Dysplastic Nodules. Advanced Ultrasound in Diagnosis and Therapy 2017;1:10. [DOI: 10.37015/audt.2018.180009] [Reference Citation Analysis]
38 Ranganath PG, Robbin ML, Back SJ, Grant EG, Fetzer DT. Practical advantages of contrast-enhanced ultrasound in abdominopelvic radiology. Abdom Radiol (NY) 2018;43:998-1012. [PMID: 29332247 DOI: 10.1007/s00261-017-1442-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
39 Kim TK, Jang H, Wilson SR. Ultrasound of Hepatocellular Carcinoma: The Important Contribution of Contrast Enhancement. In: Carr BI, editor. Hepatocellular Carcinoma. Cham: Springer International Publishing; 2016. pp. 367-90. [DOI: 10.1007/978-3-319-34214-6_24] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]